Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone Oral Suspension in Pediatric Patients With Edema Due to Heart Failure or Cirrhosis
NCT06021860Phase 4Not yet recruiting
- Sponsor
- CMP Development LLC
- Start
- Jun 2027
- Primary completion
- Jun 2028
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of spironolactone in edema, sponsored by CMP Development LLC. Planned start Jun 2027; status: not yet recruiting.
02
Drugs
spironolactone
03
Conditions
edema
Beyond the preview
Go deeper on NCT06021860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06021860.